Remove FDA Remove Pharma Remove Prescription
article thumbnail

A Non-Profit Pharma Nabs FDA Nod for Non-Prescription Naloxone Nasal Spray

MedCity News

The FDA approved RiVive, an over-the-counter version of naloxone nasal spray from Harm Reduction Therapeutics. It’s the second such approval from the FDA this year, following an affirmative decision in March for OTC Narcan.

FDA 246
article thumbnail

Regulatory Roundup: Narcan’s Nod, an ALS Adcomm, FDA Holds Lifted & More

MedCity News

Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.

FDA 307
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dear FDA: WTF?

World of DTC Marketing

SUMMARY: The FDA wants to look at how certain brand names affect consumer and health care providers’ perceptions about the efficacy and the medical conditions for which they’re indicated. This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs. The post Dear FDA: WTF?

FDA 180
article thumbnail

FDA Nod Makes Perrigo’s Opill the First Oral Contraceptive to Switch to OTC Use

MedCity News

FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.

FDA 246
article thumbnail

Pharma Marketing Keyword Research for PPC

Pharma Marketing Network

Unlike consumer brands that can use aggressive bidding strategies on high-volume keywords, pharma ads must navigate strict regulatory guidelines. For an in-depth look at how pharma companies succeed in digital advertising, visit Pharma Marketing Network. Understanding Pharma-Specific PPC Challenges 1.

article thumbnail

PPC Campaign Optimization for Pharma: Boosting ROI

Pharma Marketing Network

With strict regulations, increasing competition, and evolving ad platform policies, running a successful PPC campaign in pharma isnt as straightforward as in other industries. So, how can pharma brands ensure their Google Ads, LinkedIn campaigns, and paid social media ads are effective?

Pharma 59
article thumbnail

FDA Authorizes Better Therapeutics Mobile App for Treating Type 2 Diabetes

MedCity News

Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy.

FDA 189